Public-registry site landscape for NCT07692867, a Erectile Dysfunction study sponsored by Yangtze River Pharmaceutical Group Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07692867 (registry record) |
| Sponsor | Yangtze River Pharmaceutical Group Co., Ltd. |
| Condition(s) | Erectile Dysfunction |
| Phase | PHASE3 |
| Listed sites | 52 |
| Site countries | China |
Eichor generates a preliminary site-risk snapshot for NCT07692867 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →